Patent · US Active

Amlodipine formulations

US10959991B2 · kind B2 · utility

4Cited by

24References

20Claims

0Family size

Assignee

SILVERGATE PHARMACEUTICALS, INC. · US

Inventors

Scott Brauer · Harrisonville, US
Gerold L. Mosher · Kansas City, US

Key dates

Filing date	Jul 13, 2020
Grant date	Mar 30, 2021
Priority date	—
Expiry date	Jul 13, 2040

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P9/12
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided herein are stable amlodipine oral liquid formulations. Also provided herein are methods of using amlodipine oral liquid formulations for the treatment of certain diseases including hypertension and Coronary Artery Disease (CAD).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.